Investor Type | Firm |
Industries | BioTech • FinTech (& Financials services) • Energy • CleanTech • HealthTech (& Fitness) • Insurance (& InsurTech) • Healthcare (& Wellness) • Woman Focused |
Stages | Pre-Seed, Seed, Series A |
Investment Range | €5,000 - €10,000 |
Roivant Sciences is an investment fund that operates primarily in the fields of BioTech, FinTech, Energy, CleanTech, HealthTech, Insurance, Healthcare, and also focuses on Woman Focused initiatives. They specialize in early-stage investments, offering Pre-Seed, Seed, and Series A funding to startups that show potential for significant impact and growth in their respective industries. Roivant Sciences positions itself as a catalyst in the development of companies that are poised to redefine the landscape of healthcare and technology. With an investment range of $5,000,000 to $10,000,000, they provide substantial financial backing to help their portfolio companies scale and accelerate their go-to-market strategies. Their thesis revolves around identifying and investing in disruptive technologies and breakthrough scientific advancements that can translate into scalable and socially beneficial businesses. Roivant Sciences takes a hands-on approach, seeking opportunities where they can add value beyond capital, such as through strategic guidance, network access, and operational support. Their commitment extends to fostering diversity and inclusion by supporting woman-focused initiatives, thereby promoting a broader impact across various sectors. By leveraging their expertise and resources, Roivant Sciences aims to facilitate the progress of innovative solutions that address critical needs, ultimately contributing to the advancement of healthcare and technology for the betterment of society.